INTRODUCTION:

Any pharmaceutical plant’s main goal is to continuously produce goods with the necessary qualities and attributes at the lowest feasible cost. Despite the fact that validation studies have been carried out in the pharmaceutical business for a considerable amount of time, interest in validation is growing because of the sector’s increased focus on quality assurance programs in recent years, which are essential to an effective production operation.¹The Idea of validation first appeared in the US in 1978. Over time, the idea of validation has broadened to include everything from computerized systems for clinical trials, labeling, or process control to analytical techniques used for the quality control of drug substances and drug products.

Validation is based on, but not required by, regulatory requirements and is best understood as a crucial and essential component of cGMP ².

History of Validation:

Ted Byers and Bud Loftus, two FDA officials, first put out the idea of validation in the mid-1970s in an effort to raise the caliber of the drugs.

Galloco (1995). It was put forth as a direct solution to a number of issues with the sterility of the sizable parenteral market. The initial validation work concentrated on the steps involved in producing these goods, but it soon expanded to include the related pharmaceutical process.

Although the U.S.F.D.A. was the first to recommend the idea of process validation, the definition of the term did not appear in any of the agency’s publications until September 29, 1978. Nothing about process validation was mentioned in the cGMP requirements. ³

Definition of Validation:

The validation process is the documented evidence which provides a high degree of assurance to a desired result with predetermined compliance.⁴

Scope of Validation:⁵

· Analytical

· Instrument Calibration

· Process Utility services

· Raw materials

· Packaging materials

· Equipment

· Facilities

· Manufacturing operations

· Product Design

· Cleaning

· Operators

Types of Validation:^6,7

1) Process Validation:

a) Prospective Validation

b) Concurrent Validation

c) Retrospective Validation

d) Revalidation

2) Cleaning Validation:

3) Equipment Validation:

4) Analytical Method Validation:

Process Validation:

Defination:

Process Validation is defined as the Collection and evaluation of data, from the Process design stage throughout Production, which establishes scientific Evidence that a process is capable of Consistently delivering quality products.⁸

Advantages:

Validation makes good business sense.⁹

More rapid automation.¹⁰

Improved ability to set target parameters and control limits for routine production, correlating with validation results.¹⁰

Enlarge real time monitoring and modification of process.¹⁰

Process Optimization.^11,12

Reduction in quality cost.^11,12

Objectives:¹³

The manufacturing process, in addition to each equipment, must be validated.

The goal is to create a strong manufacturing process that consistently produces a drug product with less variation that adheres to quality criteria of purity, identity, and potency.

A validation plan for the manufacturing process should be formed and executed by engineers in order to satisfy guidelines. The validation plan usually involves just a PQ section.

If major changes occur after the initial validation will result in the need for subsequent revalidation like equipment validation.

In the end, process validation will ensure a robust product that is highly reproducible over time.

Basic Principle for Validation:^{14,15,16,17,18}

The basic principle for validation may be stated as Follows: Installation Qualification (IQ): establishing by Objective evidence that all key aspects of the process Equipment and ancillary system installation adhere to the Manufacturer’s approved specification and that the Recommendation of the supplier of the equipment are Suitably considered.

Installation Qualification (IQ):

IQ Consideration s are;

· Equipment design features (i.e. material of construction cleanability etc.)

· Installation conditions (wiring, utility, functionality, etc.)

· Calibration, preventative maintenance, cleaning Schedules.

· Safety features.

· Supplier documentation, prints, drawings and manuals.

· Software documented.

· Spare parts list.

· Environmental conditions (such as clean room Requirements, temperature, and humidity)

Operational Qualification:

OQ considerations include:

· Process control limits (time, temperature, pressure, line Speed, setup conditions, etc.)

· Software parameters.

· Raw material specifications.

· Process operating procedures.

· Material handling requirements.

· Process change control.

· Training.

· Short term stability and capability of the process, (latitude studies or control charts).

· Potential failure modes, action levels and worst-case Conditions.

Performance Qualification (PQ):

Establishing by Objective evidence that the process, under anticipated Conditions, consistently produces a product which meets All predetermined requirements.

PQ considerations include:

· Actual product and process parameters and procedures Established in OQ.

· Acceptability of the product.

· Assurance of process capability as established in OQ.

· Process repeatability, long term process stability.

NEED OF VALIDATION:

An essential component of quality assurance is validation, which is the methodical examination of facilities, systems, and procedures to ascertain if they carry out their designated tasks as intended, sufficiently, and consistently. A validated process is one that has been officially certified after it has been shown to offer a high level of assurance that consistent batches will be generated that satisfy the necessary criteria. Although validation verifies that processes have been established correctly and are under control, it does not enhance processes by itself. 3. Sufficient verification.¹⁹

STRATEGY FOR VALIDATION:

Laboratory tests utilizing samples or standards that are comparable to the unknown samples examined in the routine should be used to prove the validity of a certain approach. A validation methodology, ideally in the form of detailed instructions, should be followed during preparation and execution.^20.

1. Create an operating procedure or validation protocol.

2. Specify the method’s application goal and scope.

3. Specify the acceptance criteria and performance specifications.

4. Establish validation studies.

5. Confirm pertinent equipment performance characteristics.

6. Choose high-quality components, such as reagents and standards.

7. Conduct pre-validation tests.

8. Modify acceptance criteria and/or method parameters as needed.

9. Conduct comprehensive internal and external validation trials.

10. Create standard operating procedures for regularly implementing the approach.

11. Establish revalidation criteria.

12. Record validation experiments and findings in the validation report.

Stages of Process Validation²¹

Fig 1. Stages of process validation.

Process validation involves a series of activities taking place over the life cycle of the product and process.

Stage 1: Design of the process:

Determining the commercial manufacturing process that will be represented in planning master production and control records is known as process design. This stage aims to create a process that can reliably produce a product that satisfies its quality criteria and is appropriate for normal commercial use.

a) Building and capturing process knowledge and understanding.

Under the cGMP requirements for pharmaceuticals meant for commercial distribution that are produced using stages 2 (process qualification) and 3 (continuous process verification), general annual process design trials are exempt. Nonetheless, they must to be recorded using excellent documentation procedures as well as acceptable scientific principles and methodology. Control decisions should be recognized, recorded, and examined internally to ensure their value is maintained for proper application throughout the process and product life cycle. Key inputs from product development activities, such as the planned dosage form, the quality attribute, and a broad production pathway, are provided to the process design stage.

The process design should take into account the limitations of commercial manufacturing equipment as well as the anticipated contribution to variability posed by various component lots, production operators, climatic conditions, and measurement systems in the production context. In order to limit the overall number of tests run while maximizing knowledge gained, risk analysis tools are frequently used to select possible variables for experiment design.

A) Establishing strategy for process control:

The foundation for developing a process control strategy for each individual operation as well as the process as a whole is process knowledge and comprehension. Process control strategies can be created to minimize input variation, account for input variation during manufacturing (thereby lessening its influence on the final product), or combine the two strategies.

Stage 2: Qualification of the Process In order to ascertain whether the process is capable of reproducible commercial manufacturing, the process design is assessed at this stage. The process design is assessed to see if it can be manufactured in a commercially repeatable manner during the process qualification phase of process validation.

a) Design of a facility and qualification of utilities and equipment:

The following tasks are typically included in the qualification of utilities and equipment:

1. Choosing the building materials, operating principles, and performance characteristics of utilities and equipment according to their suitable applications.

2. Confirming that equipment and utility systems are constructed and installed in accordance with the design specification.

3. Confirming that the equipment and utility system function within all expected operating ranges in compliance with the process requirement.

Utility and equipment qualification should be addressed under specific plants or as part of a larger project plan, which should take use requirements and risk management into account.

The plan should identify the following items:

a. The criteria appropriate to access outcome

b. The timing of qualifications activities

c. The responsibilities of the relevant department and the quality unit.

d. The procedure for documenting and approving the qualification.

b) Process performance Qualification:

The second component of stage 2, process qualification, is the closest performance qualification. In order to create commercial batches, the PPQ integrates the actual facility, machinery, and skilled workers with regard to the commercial manufacturing process, control procedure, and component.

Before a producer may start commercially distributing the drug product, they must successfully finish PPQ. When compared to standard commercial production, PPQ will typically involve more sampling, more testing, and a closer examination of process performance. Enough testing and monitoring should be done to ensure consistent product quality across the batch.

c) PPQ Protocol:

A written protocol that specifies the manufacturing Conditions, controls, testing, and expected outcomes is Essential for this stage of process validation.

1. The manufacturing conditions, including operating Parameters, processing limits, and component (raw material) inputs.

2. The data to be collected and when and how it will Be evaluated.

3. Tests to be performed and acceptance criteria for Each significant processing step.

4. The sampling plan, including sampling points, Number of samples, and the frequency of Sampling for each unit operation and attributes. The number of samples should be adequate to Provide sufficient statistical confidence of quality Both within a batch and between batches. Sampling during this stage should be more Extensive than is typical during routine Production.

5. Facility design, equipment and utility qualification, staff training, material source verification, and qualification.

6. The state of the analytical techniques used to measure the product, in-process constituents, and process are being validated.

Stage 3. Continued process qualification:

Continuous assurance that the process stays in a condition of control (the validation state) during commercial manufacturing is the aim of the third validation stage.

To do this, a system or systems for identifying unscheduled departures from the process as intended are necessary. The information acquired during this phase may hint to ways to modify some aspect of the process or product, such as the operating conditions (ranges and set points), process controls, component, or in-process material properties, in order to enhance and/or optimize the process.

Reason for Process Validation:²²

· New or existing items in accordance with SUPAC modifications.

· The production site has changed.

· The batch size has changed.

· A change in the equipment.

· Process modification for current goods.

· Composition or component changes.

· The crucial control settings have changed.

· A shift in the critical excipient or API vendor.

· A modification to the input material specification.

· During the Annual Product Review (APR), abnormal trends in the product’s quality criteria were reviewed.

Types of Process Validation:^23,24

1) Prospective Validation:

It can be defined as the recognized written evidence that a system performs as promised in accordance with a prearranged agreement. Usually, this validation is done before a new product or one created using an altered manufacturing process is released. Conducted using consecutive batches at a minimum of three consecutive manufacturing sizes.

2) Retrospective Validation:

It is defined as the recognized written evidence, based on a prearranged agreement, that a system performs as promised. This validation is typically done before a new product or one created using an altered manufacturing process is distributed. Conducted on consecutive batches of at least three different manufacturing sizes.

3) Concurrent Validation:

With the exception of the operational company selling the product to the general public or at market value during the qualification race, concurrent validation is similar to prospective validation. This validation necessitates product testing and process monitoring of crucial production steps. It is a summary of a validation procedure, or a specific section of it. This is done whenever there is a formulation, equipment, facility, or site location modification or renewal.

4) Revalidation:

When batch size is altered or when batches are consecutive and do not relate to product and process specifications, revalidation is finished. Re-validation give the proof that modifications in a process and the process environment that are launch, do not adversely effect process characteristics and product quality. The same documentation requirements as for the process’s initial validation will apply.

Applications:

1)Reduction of quality cost²⁵

Through proper validation, cost of the following procedures can be optimized.

a) Preventive costs are costs incurred in order to prevent Failure and reduce appraisal costs.

b) Appraisal costs of inspection, testing and quality Evaluation.

c) Internal failure costs.

2) Safety:²⁶

Validation can also result in increased operator safety. Properly standardized, validated instruments and devices used To reduce accidents and results in safety.

Validation can also Result in the increase in operation safety. E.g. instruments used on equipment that intended to operate at certain temperature And pressures must be dependable i.e. They need to be Calibrated.

3) Process Optimization.²⁷

The development of the facility, equipment system, closures Etc. results in a product that encounter quality necessities at The lesser costs. Trained and qualified personnel’s are the key Elements in the process optimization that results in upgrading efficiency and productivity.

4) Assurance of quality:²⁷

Validation and the process control are one of the important Protocol of GMPs. Without validation and controlled process.

It is impossible to attain quality products. Hence validation is A key element in assuring the quality of the product.

5) Better consumer quality:²⁸

Through proper validation, market recall is evaded which Results in better consumer care and quality of the product. Quality costs are divided in to four categories.

They are:

Preventive costs.

Appraisal costs.

Internal failure costs.

External failure costs.

CONCLUSION:

"Validation" is most commonly used in the domains of pharmaceutical research, production, and finished product specifications. The key to an industry is the consistency and dependability of a tried-and-true process for producing a high-quality product. The most important and well-known cGMP parameters is Pharmaceutical Process Validation. Process validation can be used broadly to production procedures and serves the objective of assisting producers in understanding the quality requirements for a quality management system (QMS) with relation to process validation.

REFERENCES:

1. Sharma A, Saini S; Process Validation of Solid Dosage Form: A Review. International Journal of Research in Pharmacy and Science, 2013; 3(2): 12- 30.

2. Kaur H, Singh G, Seth N; Pharmaceutical Process Validation: A Review. 2013; 3(4): 189-194.

3. Chapman KG. A history of validation in the United States. Pharmaceutical Technology. 1991; 15(10).

4. Sharma PP. Validation in Pharmaceutical Industry (6^th ed). United Kingdom: Informa Healthcare Publication; 2016: 51-70.

5. Ashwini R. Ghorpade, et al. Review on vesicular Drug Delivery system: Aquaomes. Asian Journal of Research in Chemistry. 2024.

6. Ira R. Berry second and Robert A. Nash. Pharmaceutical Process Validation, Second edition, Page no: 168.

7. Verma P, Madhav NS, KR Gupta V. A review article on Pharmaceutical validation and process controls. The Pharma Innovation. 2012; 1(7, Part A): 51

8. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UC M070336.pdf 22 Nov 8.36 pm.

9. Sharma V, Seth N. Industrial Process Validation of Solid Oral Dosage Form: A Review. International Research Journal of Pharmacy. 2013: 67

10. Vrushali G Raut, et al. A Review Mechanism of Role of superdisintogrants in the Development of Mouth Dissolving Tablets. International Journal; Pharma Tech Research. 2011.

11. R.R Shinde, et al. Pharmacosome as a vesicular Drug Delivery system. Asian Journal of Research in Pharmaceutical Science. 2022.

12. Shivani Deshmukh, et al. A Review on Diverging approaches to Fabricate Polymeric Nanoparticles. Asian Journal of Research in Pharmaceutical Science. 2023.

13. Shital. R. Khot, Rohini. S. Khobare, P. S. Patil, Sachinkumar. V. Patil. Review Article Process Validation as Quality Assurance Tool. 2021: 27

14. Guidance for Industry: Process Validation: General Principles and Practices. U.S. Department of Health and Human Services. 2011: 7

15. Quality Management System – Process Validation Guidance GHTF/SG3/N99-10:2004 (Edition 2). page no 7

16. Sanket Nikam, et al. Pulsatile Delivery of Drug for a Range of Diseases. Asian Journal of Research in Pharmaceutical Sciences. 2022.

17. Bhagyashri V. Aiwale, et al. A Review on in situ Gel of Gastro Retentive Drug Delivery System. Asian Journal of Research in Pharmaceutical Sciences. 2022.

18. Kathiresan K, Moorthi C, Prathyusha Y, Gade B. R, Reddy B. K, Manavalan R, An overview of pharmaceutical validation; Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2010; 1(4); 1026.

19. Pankaj Verma, N.V. Satheesh Madhav, Vinay Gupta. A Review article on Pharmaceutical Validation and Process Controls. 2012 52

20. Kaustubh Jagtap, et al. Quality by Design (gbd) concept Review in Pharmaceutical. Asian Journal of Research in Chemistry. 2022.

21. Nash R.A., Alfred H.W. Pharmaceutical Process Validation, 3^rd ed., Marcel Dekker, New York. 2003: 159-180.

22. Guide to Inspections of Oral Solid Dosage Forms Pre/post Approval Issue for Development and Validation. 2010; 1/94: 2010.

23. US Food and Drug Administration. Guideline on general Principles of Process Validation. US FDA: Rockville, MD. 1987.

24. Jatto E, Okhamafe AO. An Overview of Pharmaceutical Validation and Process Controls in Drug Development. Tropical Journal of Pharmaceutical Research. 2002; 1(2): 115-22.

25. Nash RA. Process validation: a 17-year retrospective of Solid-dosage forms. Drug Development and Industrial Pharmacy. 1996; 22(1): 25-34

26. Bharatee Chaudhari, Kartika Daniel. A Validated RP-HPLC Method for simultaneous Estimation of Tizanidine and Nimesulide in Bulk and Pharmaceutical. Research Journal of Pharmacy and Technology. 2020

27. Neha B. Waghmode, et al. Review on Colon Targeted Drug Delivery System. Asian Journal of Research in Chemistry. 2024.

28. Vrushali G. Raut, et al. Influence of newly Synthesized Superdisintegrant on Dissolution Rate Enhancement of Carbomazepine using Liquid solid Compact Technique. Asian Journal of Research in Pharmaceutical Sciences. 2022